Unrelated Bone Marrow Transplantation with a Reduced Toxicity Myeloablative Conditioning Regimen in Wiskott-Aldrich Syndrome
Journal of Korean Medical Science
;
: 146-148, 2008.
Article
in English
| WPRIM
| ID: wpr-222187
ABSTRACT
Wiskott-Aldrich syndrome (WAS) is an X-linked congenital immune-deficiency syndrome, and bone marrow transplantation (BMT) has become a curative modality. However, the transplant with the alternative donor needed more intensive conditioning with increased treatment-related toxicities. Recently, fludarabine-based reduced toxicity myeloablative conditioning regimens have been developed for adult myeloid malignancies with promising results of good engraftment and low treatment-related toxicities. To increase the engraftment potential without serious complications, a boy with WAS received successful unrelated BMT with a reduced toxicity myeloablative conditioning regimen composed of fludarabine (40 mg/m(2) on days -8, -7, -6, -5, -4, -3), busulfan (0.8 mg/kg i. v. q 6 hr on days -6, -5, -4, -3), and thymoglobulin (2.5 mg/kg on days -4, -3, -2). This novel conditioning regimen could improve the outcome of allogeneic transplantation for other non-malignant diseases such as congenital immune-deficiency syndromes or metabolic storage diseases.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Wiskott-Aldrich Syndrome
/
Bone Marrow Transplantation
/
Transplantation Conditioning
/
Graft vs Host Disease
Limits:
Child, preschool
/
Humans
/
Male
Language:
English
Journal:
Journal of Korean Medical Science
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS